✎ Add Post
Click here for Advocacy Resources
Quest to Add Molecular Test When HCV Screen is Positive
Summary of Panel on Community/Provider Partnerships at AASLD
On January 28, 2016, the fixed-dose combination elbasvir-grazoprevir (Zepatier) was approved by the United States FDA for the treatment of chronic hepatitis C genotypes 1 or 4 infection in adults.....
Proposed Decision Memo Due Date: 07/21/2016
Hepatitis C, Acute 2016 Case Definition